386 Matching Annotations
  1. Last 7 days
    1. 2021-07-21

    2. Staff, Fox News. “McEnany Encourages People to Get COVID Vaccine: It Reduces Your Risk of Transmitting the Virus.” Text.Article. Fox News. Fox News, July 21, 2021. https://www.foxnews.com/media/mcenany-encourages-people-to-get-covid-vaccine-variant.

    3. "Outnumbered" co-host Kayleigh McEnany discussed why she got vaccinated against COVID-19 on Wednesday, saying she trusted the vaccine development process and its effectiveness in the prevention of getting and transmitting the virus.KAYLEIGH MCENANY: Like Congressman Steve Scalise, I had COVID-19. Even though I was asymptomatic, I went and got the vaccine for a few reasons. Well first, let me say as I mentioned yesterday, I saw President Trump oversee this process. He appointed Dr. Stephen Hahn at the FDA, who approved this vaccine. He appointed Robert Redfield at the CDC. I got the vaccine because one, it could keep you from getting a variant. Number two, even if you get a variant, you're 95 percent less likely to be hospitalized. Our elderly, our most vulnerable … More important than any of that is it reduces your risk of transmitting the virus; so if you have a grandmother or a grandfather or a parent, do it for them, if not for yourself, even if you're a young person.
    4. McEnany encourages people to get COVID vaccine: It reduces your risk of transmitting the virus
    1. 2021-07-21

    2. Tada, Takuya, Hao Zhou, Marie I. Samanovic, Belinda M. Dcosta, Amber Cornelius, Mark J. Mulligan, and Nathaniel R. Landau. “Comparison of Neutralizing Antibody Titers Elicited by MRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants.” BioRxiv, July 19, 2021, 2021.07.19.452771. https://doi.org/10.1101/2021.07.19.452771.

    3. The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and an adenoviral vector-based vaccine against variant pseudotyped viruses were compared. BNT162b2 and mRNA-1273-elicited antibodies showed modest neutralization resistance against Beta, Delta, Delta plus and Lambda variants whereas Ad26.COV2.S-elicited antibodies from a significant fraction of vaccinated individuals were of low neutralizing titer (IC50 <50). The data underscore the importance of surveillance for breakthrough infections that result in severe COVID-19 and suggest the benefit of a second immunization following Ad26.COV2.S to increase protection against the variants.
    4. 10.1101/2021.07.19.452771
    5. Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
    1. 2021-07-14

    2. Barouch, Dan H., Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, et al. “Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.” New England Journal of Medicine 0, no. 0 (July 14, 2021): null. https://doi.org/10.1056/NEJMc2108829.

    3. 10.1056/NEJMc2108829
    4. Interim immunogenicity and efficacy data for the Ad26.COV2.S vaccine (Johnson & Johnson–Janssen) against coronavirus disease 2019 (Covid-19) have recently been reported.1-3 We describe here the 8-month durability of humoral and cellular immune responses in 20 participants who received the Ad26.COV2.S vaccine in one or two doses (either 5×1010 viral particles or 1011 viral particles) and in 5 participants who received placebo.2 We evaluated antibody and T-cell responses on day 239, which was 8 months after the single-shot vaccine regimen (in 10 participants) or 6 months after the two-shot vaccine regimen (in 10 participants), although the present study was not powered to compare the two regimens.3 We also report neutralizing antibody responses against the parental WA1/2020 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as against the SARS-CoV-2 variants D614G, B.1.1.7 (alpha), B.1.617.1 (kappa), B.1.617.2 (delta), P.1 (gamma), B.1.429 (epsilon), and B.1.351 (beta).
    5. Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
    1. 2021-07-23

    2. the Guardian. “Australian Medical Association Says NSW Covid Lockdown Failing and Urges Change to AstraZeneca Advice,” July 23, 2021. http://www.theguardian.com/australia-news/2021/jul/23/australian-medical-association-says-nsw-covid-lockdown-failing-and-urges-change-to-astrazeneca-advice.

    3. The president of the Australian Medical Association, Dr Omar Khorshid, says it is unlikely lockdown measures can contain the Delta outbreak in New South Wales and has urged the Australian Technical Advisory Group on Immunisation (Atagi) to recommend the AstraZeneca vaccine for more age groups.Currently, the Atagi advice recommends the Pfizer vaccine, which is in short supply and high demand in Australia, “as the preferred vaccine for those aged 16 to under 60 years” due to the risk of rare but severe clotting known as TTS linked to AstraZeneca and more frequent in the under-60 age group.
    4. Australian Medical Association says NSW Covid lockdown failing and urges change to AstraZeneca advice
    1. 2021-07-26

    2. The Jerusalem Post | JPost.com. “Israel Might Soon Decide to Give Booster to the Elderly.” Accessed July 28, 2021. https://www.jpost.com/breaking-news/coronavirus-in-israel-1398-new-cases-208-percent-of-tests-return-positive-674917.

    3. Israel might decide to give elderly people a third coronavirus vaccine without waiting for authorization from the US Food and Drug Administration, as the number of serious patients – while still limited – started to climb at a significant pace in the past few days, reaching 125 on Monday night, 24 more than in the morning.“The significant decrease in vaccine efficacy against serious morbidity worries us,” Health Ministry’s Director General Prof. Nachman Ash said during a press briefing. “It could be that in light of these numbers, we will also start administering a third vaccine.”According to reports in Israeli media, most of the experts advising the Health Ministry support the decision in principle, even though the debate has been very heated.The decision might be made in the coming weeks, but some details remain open – for example whether to give the booster to people over 60 or over 70.
    4. Israel might soon decide to give booster to the elderly
    1. 2021-07-22

    2. Park, Jiwon, Seungmin Lee, Sunhae Sul, and Dongil Chung. “Depression Symptoms Mediate Mismatch Between Perceived Severity of the COVID-19 Pandemic and Preventive Motives.” Frontiers in Psychology 0 (2021). https://doi.org/10.3389/fpsyg.2021.650042.

    3. The present study monitored changes in beliefs about the coronavirus disease 2019 (COVID-19) pandemic, depressive symptoms, and preventive motives between the first and second waves in South Korea using an online survey administered to 1,144 individuals nationally representative for age, gender, and areas of residence. While participants correctly updated their beliefs about the worsening pandemic situations, the perceived importance of social distancing did not change, and their motives to follow prevention measures shifted toward compulsory rather than voluntary motives. This inconsistency appeared to be mediated by depressive symptoms, such that negative belief changes followed by increased depressive symptoms were associated with the decreased perceived importance of social distancing and decreased voluntary motives. Our data highlights the importance of psychological responses to the dynamically evolving pandemic situations in promoting preventive behaviors.
    4. 10.3389/fpsyg.2021.650042
    5. Depression Symptoms Mediate Mismatch Between Perceived Severity of the COVID-19 Pandemic and Preventive Motives
    1. 2021-07-27

    2. “Covid-19: CDC Brings Back Indoor Mask Guidance for Virus Hot Spots.” BBC News, July 27, 2021, sec. US & Canada. https://www.bbc.com/news/world-us-canada-57989777.

    3. Americans living in areas seeing new surges of Covid-19 have been advised to wear masks indoors again - even if they are fully vaccinated.The Centers for Disease Control and Prevention (CDC) made the announcement on Tuesday, citing the spread of the highly contagious Delta variant.There were 89,418 new cases on Monday, Johns Hopkins University reported.Masking has been a controversial subject in the US, and one politicised since the start of the pandemic.The updated guidance says in public indoor settings, everyone should wear masks to prevent the spread of the Delta variant.Notably, this includes students and staff at schools, where masking has been a contentious issue.In a statement following the announcement, President Joe Biden said masking students "is inconvenient" but would allow them to learn alongside classmates "with the best available protection".
    4. Covid-19: CDC brings back indoor mask guidance for virus hot spots
    1. 2021-07-22

    2. the Guardian. “Rates of Double-Jabbed People in Hospital Will Grow – but That Does Not Mean Covid Vaccines Are Failing,” July 22, 2021. http://www.theguardian.com/world/2021/jul/22/rates-of-double-jabbed-people-in-hospital-will-grow-but-that-does-not-mean-covid-vaccines-are-failing.

    3. The next wave of Covid will be different. When cases soared in spring and winter last year lockdowns rapidly brought them back under control. This time it will be vaccines that do the hard work.But Covid jabs are not a perfect shield. They slow the spread of the virus, help prevent disease, and reduce the risk of dying. They do not bring all this to an end.In the months ahead many thousands of people will be in hospital with Covid. What may seem more troubling is that ever more will have received two vaccination doses.This does not mean the immunisations are not doing their job. Real-world data from Public Health England show that two shots of the Oxford/AstraZeneca or of the Pfizer/BioNTech vaccine are 92% and 96% effective, respectively, against hospital admission.
    4. Rates of double-jabbed people in hospital will grow – but that does not mean Covid vaccines are failing
    1. 2021-07-22

    2. Snopes.com. “No, There Weren’t More COVID-19 Vaccine Deaths Than COVID-19 Deaths.” Accessed July 23, 2021. https://www.snopes.com/fact-check/covid-vax-deaths-vs-covid-deaths/.

    3. On July 17, 2021, the junk news site Gateway Pundit published a misleading story with a headline falsely reporting there have been more deaths from the vaccines for COVID-19 than the virus itself. The headline read, “For Second Week in a Row: More COVID-19 Vaccination Deaths than COVID-19 Deaths in the US According to CDC and VAERS Websites.” VAERS stands for Vaccine Adverse Event Reporting System, a website monitored by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). The figures on the site reflect the fact that it’s a public reporting tool, not a vaccine death toll. “VAERS accepts reports of any adverse event following any vaccination,” according to the CDC. “Reports of adverse events to VAERS following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem.” The CDC also said the COVID-19 vaccines are safe, and that reports of deaths from the vaccines are rare:
    4. No, There Weren’t More COVID-19 Vaccine Deaths Than COVID-19 Deaths
  2. Jul 2021
    1. 2021-07-14

    2. Sky News. “COVID-19: Rapid Lateral Flow Tests 95% Effective at Detecting COVID If Used When Symptoms Start, Study Shows.” Accessed July 19, 2021. https://news.sky.com/story/covid-19-rapid-lateral-flow-tests-95-effective-at-detecting-covid-if-used-when-symptoms-start-study-shows-12355179.

    3. Rapid lateral flow tests are 95% effective at detecting coronavirus if they are used at the onset of infection or as soon as symptoms start, a new study suggests.Scientists have previously said that lateral flow tests (LFTs) are less sensitive at picking up COVID-19 cases than laboratory tested PCR swabs. But a study of more than 2,500 people with flu-like symptoms has shown that LFTs picked up 95% of the coronavirus cases that the PCR tests did.It also correctly identified 89% of COVID cases as negative.
    4. COVID-19: Rapid lateral flow tests 95% effective at detecting COVID if used when symptoms start, study shows
    1. 2107.06476
    2. 2021-07-14

    3. Hill, Ryan, Yian Yin, Carolyn Stein, Dashun Wang, and Benjamin F. Jones. “Adaptability and the Pivot Penalty in Science.” ArXiv:2107.06476 [Physics], July 13, 2021. http://arxiv.org/abs/2107.06476.

    4. The ability to confront new questions, opportunities, and challenges is of fundamental importance to human progress and the resilience of human societies, yet the capacity of science to meet new demands remains poorly understood. Here we deploy a new measurement framework to investigate the scientific response to the COVID-19 pandemic and the adaptability of science as a whole. We find that science rapidly shifted to engage COVID-19 following the advent of the virus, with scientists across all fields making large jumps from their prior research streams. However, this adaptive response reveals a pervasive "pivot penalty", where the impact of the new research steeply declines the further the scientists move from their prior work. The pivot penalty is severe amidst COVID-19 research, but it is not unique to COVID-19. Rather it applies nearly universally across the sciences, and has been growing in magnitude over the past five decades. While further features condition pivoting, including a scientist's career stage, prior expertise and impact, collaborative scale, the use of new coauthors, and funding, we find that the pivot penalty persists and remains substantial regardless of these features, suggesting the pivot penalty acts as a fundamental friction that governs science's ability to adapt. The pivot penalty not only holds key implications for the design of the scientific system and human capacity to confront emergent challenges through scientific advance, but may also be relevant to other social and economic systems, where shifting to meet new demands is central to survival and success.
    5. Adaptability and the Pivot Penalty in Science
    1. 2021-07-16

    2. “Analysis | Fox News’s Dismissive Vaccine Coverage Is Particularly Dangerous for Its Relatively Old Audience.” Washington Post. Accessed July 19, 2021. https://www.washingtonpost.com/politics/2021/07/16/fox-newss-dismissive-vaccine-coverage-is-particularly-dangerous-its-relatively-old-audience/.

    3. A few weeks ago, Fox News host Laura Ingraham did what she has done so often over the past year: scoffed at the danger posed by the coronavirus pandemic.On that night, she was interviewing Florida Gov. Ron DeSantis (R). She played a snippet of an interview with a doctor warning that we could see the same pattern with infections that we saw last year: that during the heat of summer, new cases would surge in the Sun Belt and Florida.
    4. Fox News’s dismissive vaccine coverage is particularly dangerous for its relatively old audience
    1. 2021-07-16

    2. Prunas, Ottavia, Joshua L. Warren, Forrest W. Crawford, Sivan Gazit, Tal Patalon, Daniel M. Weinberger, and Virginia E. Pitzer. “Vaccination with BNT162b2 Reduces Transmission of SARS-CoV-2 to Household Contacts in Israel.” MedRxiv, July 16, 2021, 2021.07.13.21260393. https://doi.org/10.1101/2021.07.13.21260393.

    3. 10.1101/2021.07.13.21260393
    4. The individual-level effectiveness of vaccines against clinical disease caused by SARS-CoV-2 is well-established. However, few studies have directly examined the effect of COVID-19 vaccines on transmission. We quantified the effectiveness of vaccination with BNT162b2 (Pfizer-BioNTech mRNA-based vaccine) against household transmission of SARS-CoV-2 in Israel. We fit two time-to-event models – a mechanistic transmission model and a regression model – to estimate vaccine effectiveness against susceptibility to infection and infectiousness given infection in household settings. Vaccine effectiveness against susceptibility to infection was 80-88%. For breakthrough infections among vaccinated individuals, the vaccine effectiveness against infectiousness was 41-79%. The overall vaccine effectiveness against transmission was 88.5%. Vaccination provides substantial protection against susceptibility to infection and slightly lower protection against infectiousness given infection, thereby reducing transmission of SARS-CoV-2 to household contacts.One-Sentence Summary Vaccination reduced both the rate of infection with SARS-CoV-2 and transmission to household contacts in Israel.
    5. Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
    1. 2021-07-12

    2. Luoto, Severi, Marjorie L. Prokosch, Marco Antonio Correa Varella, Indrikis Krams, and Corey L. Fincher. “Editorial: Coronavirus Disease (COVID-19) and Its Psychobehavioral Consequences.” Frontiers in Psychology 0 (2021). https://doi.org/10.3389/fpsyg.2021.723282.

    3. The presence of pathogens has imposed constant threats to human survival and reproduction. Selective pressures exerted by pathogens have shaped our array of immune functions—including physiological, psychological, and behavioral immune systems. Pathogens and epidemics have plagued humankind and our ancestors from their dawn, yet despite advances in hygiene and medicine, these threats remain with us today. In 2020–2021, pathogens have become a particularly salient part of everyday life as we have faced a worldwide outbreak of SARS-CoV-2. We launched this Research Topic with the specific recognition that evolutionary approaches, which acknowledge the biological forces shaping and underlying human cognition and behavior, are uniquely positioned within psychology and behavioral science to offer insights on the responses to and outcomes of the COVID-19 pandemic. The collection of 14 articles published in this Research Topic has surpassed our original vision, introducing diverse evolutionary perspectives on various aspects of the COVID-19 pandemic. Varella et al. captured the importance of an evolutionary approach to COVID-19 by stating that “Everything in pandemics is stamp collection except in the light of evolution.” Research focused on pandemics without an explicit evolutionary framework can also be very valuable as it can offer the pieces of the jigsaw puzzle that evolutionarily oriented researchers need to integrate in their quest to understand the bigger picture.
    4. 10.3389/fpsyg.2021.723282
    5. Editorial: Coronavirus Disease (COVID-19) and Its Psychobehavioral Consequences
    1. 2021-07-12

    2. Yap, Suhui, Albert Lee, Li-Jun Ji, Ye Li, and Ying Dong. “Cultural Differences in People’s Psychological Response to COVID-19.” Frontiers in Psychology 0 (2021). https://doi.org/10.3389/fpsyg.2021.636062.

    3. 10.3389/fpsyg.2021.636062
    4. The present research studied Chinese and Euro-Canadian students during the COVID-19 pandemic, focusing on their affect, optimism, well-being, and meaning in life. The results revealed both differences and similarities across cultures. As predicted, Chinese participants reported more positive affect and less negative affect, higher optimism, higher state psychological well-being, and higher meaning presence, compared to Euro-Canadian participants. The findings were replicated after a week’s delay. Analyses on longitudinal data showed that state optimism, state well-being, and meaning presence influenced one another over time. These variables also mediated the cultural differences in one another. These results are consistent with cultural work on naïve dialecticism and non-linear lay theory of change. Results also demonstrate underlying relationships among the constructs that are common to both cultural groups. Broadly, the present research highlights the impact of culture on people’s response to challenging life situations and the mechanisms underlying these cultural differences.
    5. Cultural Differences in People’s Psychological Response to COVID-19
    1. Logg, Jennifer M., and Charles A. Dorison. “Pre-Registration: Weighing Costs and Benefits for Researchers.” Organizational Behavior and Human Decision Processes 167 (November 1, 2021): 18–27. https://doi.org/10.1016/j.obhdp.2021.05.006.

    2. 2021-11

    3. 10.1016/j.obhdp.2021.05.006
    4. In the past decade, the social and behavioral sciences underwent a methodological revolution, offering practical prescriptions for improving the replicability and reproducibility of research results. One key to reforming science is a simple and scalable practice: pre-registration. Pre-registration constitutes pre-specifying an analysis plan prior to data collection. A growing chorus of articles discusses the prescriptive, field-wide benefits of pre-registration. To increase adoption, however, scientists need to know who currently pre-registers and understand perceived barriers to doing so. Thus, we weigh costs and benefits of pre-registration. Our survey of researchers reveals generational differences in who pre-registers and uncertainty regarding how pre-registration benefits individual researchers. We leverage these data to directly address researchers’ uncertainty by clarifying why pre-registration improves the research process itself. Finally, we discuss how to pre-register and compare available resources. The present work examines the who, why, and how of pre-registration in order to weigh the costs and benefits of pre-registration to researchers and motivate continued adoption.
    5. Pre-registration: Weighing costs and benefits for researchers
    1. 2021-03-23

    2. Antonova, Elena, Karoly Schlosser, Rakesh Pandey, and Veena Kumari. “Coping With COVID-19: Mindfulness-Based Approaches for Mitigating Mental Health Crisis.” Frontiers in Psychiatry 12 (2021). https://doi.org/10.3389/fpsyt.2021.563417.

    3. 10.3389/fpsyt.2021.563417
    4. The novel coronavirus disease COVID-19 that first emerged in Wuhan, China, in Nov-Dec 2019 has already impacted a significant proportion of the world population. Governments of many countries imposed quarantines and social distancing measures in 2020, many of which remain in place, to mitigate the spread of the SARS-Cov-2 virus causing the COVID-19 disease. The direct impact of COVID-19 on people infected with the virus, their families and the health care workers, as well as the impact of the mitigation measures such as quarantine, social distancing, and self-isolation on the rest of the population have contributed to a global mental health pandemic, including anxiety, depression, panic attacks, posttraumatic stress symptoms, psychosis, addiction, obsessive-compulsive disorder, and suicidality. These effects are present acutely (for example, due to fear of contamination or losing loved ones, effects of quarantine/isolation, withdrawal of community and social services, etc.) and may continue long after the pandemic is over (for example, due to bereavement, unemployment, financial losses, etc). The COVID-19 pandemic has triggered mental health problems in people without previous history of mental illness, as well as worsened the symptoms in those with pre-existing psychiatric diagnosis. Therefore, the global effort is called for to deal with this mental health pandemic secondary to COVID-19 itself to address the emergence of new as well as the exacerbation of the existing mental health issues. Conversely, this global context provides an extraordinary opportunity for studying individual differences in response to and resilience in the face of physical and psychological threat, challenge to “normal” way of life, and long-term uncertainty. In this viewpoint article we outline the particular suitability of mindfulness, its skills and mechanisms, as an approach to the prevention and management of mental health issues, as well as to the promotion of well-being and building the foundations of adaptability and flexibility in dealing with the long-term uncertainty and profound changes to the social, economic, and possibly political systems as this pandemic continues to unfold.
    5. Coping With COVID-19: Mindfulness-Based Approaches for Mitigating Mental Health Crisis
    1. 2021-06-03

    2. There are 5variants of concern and 9variants under investigation (Table 1).This report has been published to continue to sharedetailed surveillance ofDelta (VOC-21APR-02,B.1.617.2).A separate report is published covering ourroutine data on allothervariants of concern and variants under investigation. These additional specialist technical briefings represent early data and analysis on an emerging variant and findings have a high level of uncertainty.
    3. SARS-CoV-2 variants of concern and variants under investigationin EnglandTechnical briefing 14
    1. 2021-02-25

    2. Draft, First. “Finding Misinformation with ‘Rumor Cues.’” Medium, February 25, 2021. https://medium.com/1st-draft/finding-misinformation-with-rumor-cues-ee1355fb82ae.

    3. If you’re a reporter, getting your queries right really matters.In 2015, Daniel Victor of The New York Times was searching for witnesses to an incident on a plane involving a female passenger and a Hasidic Jewish man who didn’t feel comfortable sitting next to her. Victor found that querying for “hasidic” and “flight” on social media brought up a lot of people talking about the incident, but not people who were actually there.But then he discovered something. There were three words that could identify genuine eyewitness accounts: “me,” “my” and “I.”“Most people relating a personal experience — [also known as] good sources — will use [them],” Victor explained. “Most people observing from afar — aka, useless sources — won’t.”For anyone researching social media, skillful query design is critical. Get it wrong and you won’t find what you’re looking for. Get it right and you can discover surprising things that others are missing
    4. Finding misinformation with ‘rumor cues’
    1. 2021-05-20

    2. This report summarises the information from the surveillance systems which are used to monitor Coronavirus Disease 2019 (COVID-19), influenza, and other seasonal respiratory viruses in England. References to COVID-19 represent the disease name and SARS-CoV-2 represent the virus name. The report is based on data from week 19(between 10and 16May2021) and for some indicators daily data up to 18May2021. Surveillance indicators suggest that at a national levelCOVID-19 activity remained stablein week 19of 2021. There is currently limited testing for other respiratory viruses, however, laboratory indicators suggest that influenza activity is low. Overall case rates remained stablein week 19. Case rates remained stable in the majority of age groups andregionsand increased in certain ethnic groups.Overall Pillar 1 and Pillar 2 positivity remained stablecompared to the previous week.The number of reported acute respiratory incidents in the past week increasedcomparedto the previous week. SARS-CoV-2 was identified in the majority of these.COVID-19 hospitalisationsdecreased further in week 19and havebeen decreasing since week 2.Deaths with COVID-19decreased further in week 19and havebeen decreasing since week 3. This continued decrease is likely to reflect the impact of both social and physical distancing measures and the vaccination programme.COVID-19 vaccine coverage was 49.4% for dose 1 at the end of week 19, reaching over 90% in all cohorts over the age of 65years andover 80% in all cohorts over 50years. COVID-19 vaccine coverage was 27.8% for dose 2 at the end of week 19.The impact of the vaccination programme is particularly notable in the seroprevalence data which indicates that approximately71.8% of the population have antibodies to SARS-CoV-2 from either infection or vaccination, compared to 15.8% from infection alone.Increases in seropositivity for vaccination or infection continue to be observed in older age groups, as well as sharp increases in those aged 50 to 59 and 40 to 49,following vaccination rollout.Through Respiratory Datamart, there were noinfluenza positive samples detected in week 19. Other indicators for influenza such as hospital admissions and GP influenza-like illness consultation rates remain low. Slight decreasesin rhinovirus activity were noted this week.
    3. Weekly national Influenza andCOVID-19 surveillance report
    1. California Science Center. ...“...If Vaccines Are Safe and Effective?” Accessed July 2, 2021. https://californiasciencecenter.org//funlab/ever-wonder/2021-05-26/if-vaccines-are-safe-and-effective.

    2. 2021-05-26

    3. As time goes on, it’s getting easier to get a COVID-19 vaccine—in many places in L.A. County you can now just walk up to a vaccine site without an appointment. Millions of Californians have already gotten their Fauci Ouchie, but it’s also okay to have questions about the vaccine. Do you ever wonder if vaccines are safe and effective? This very question came up when we last talked to Kenneth Phillips—if you haven’t listened to his episode about contact tracing yet, be sure to check it out. Ken recommended that we talk to Shira Shafir (@IDPhD), a professor and infectious disease epidemiologist at the UCLA Fielding School of Public Health. She’s also working with the L.A. County Department of Public Health to help train contact tracers. She answered all our questions about the vaccines, from how scientists and doctors know they’re safe to when we might be able to start vaccinating younger kids.
    4. ...if vaccines are safe and effective?
  3. Jun 2021
    1. 2021-06-28

    2. Mahase, Elisabeth. “Covid-19: GPs Urge Government to Clear up Confusion over Symptoms.” BMJ 373 (June 28, 2021): n1654. https://doi.org/10.1136/bmj.n1654.

    3. GPs have called on the government to update the official list of covid-19 symptoms after seeing patients shun tests to check their infection status because they don’t believe they have been infected by SARS-CoV-2. They also said that a public communication campaign was needed to inform the public about the limitations of lateral flow tests and vaccination.
    4. 10.1136/bmj.n1654
    5. Covid-19: GPs urge government to clear up confusion over symptoms
    1. 2021-06-03

    2. Singh, Urvashi B., Mercy Rophina, Dr Rama Chaudhry, Vigneshwar Senthivel, Kiran Bala, Rahul C. Bhoyar, Bani Jolly, et al. “Variants of Concern Responsible for SARS-CoV-2 Vaccine Breakthrough Infections from India.” OSF Preprints, June 3, 2021. https://doi.org/10.31219/osf.io/fgd4x.

    3. Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin.Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April-May 2021 in Delhi, were the predominant lineages among breakthrough infections.
    4. 10.31219/osf.io/fgd4x
    5. Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India
    1. Office for Science and Society. “Don’t Fall for the ‘VAERS Scare’ Tactic.” Accessed June 21, 2021. https://www.mcgill.ca/oss/article/covid-19-critical-thinking-health/dont-fall-vaers-scare-tactic.

    2. 2021-06-18

    3. he Vaccine Adverse Event Reporting System or VAERS is being misused by anti-vaxxers to terrify the public. It’s a shame because VAERS plays a vital role in detecting important but rare reactions caused by vaccines. The weaponization of VAERS by anti-vaccine activists serves as a reminder that having access to more information does not always lead to better decisions. Information needs to be correctly interpreted to guide us in the right direction.
    4. Don’t Fall for the ‘VAERS Scare’ Tactic
    1. Naveca, Felipe Gomes, Valdinete Nascimento, Victor Costa de Souza, André de Lima Corado, Fernanda Nascimento, George Silva, Ágatha Costa, et al. “COVID-19 in Amazonas, Brazil, Was Driven by the Persistence of Endemic Lineages and P.1 Emergence.” Nature Medicine, May 25, 2021, 1–9. https://doi.org/10.1038/s41591-021-01378-7.

    2. 2021-05-25

    3. 10.1038/s41591-021-01378-7
    4. The northern state of Amazonas is among the regions in Brazil most heavily affected by the COVID-19 epidemic and has experienced two exponentially growing waves, in early and late 2020. Through a genomic epidemiology study based on 250 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from different Amazonas municipalities sampled between March 2020 and January 2021, we reveal that the first exponential growth phase was driven mostly by the dissemination of lineage B.1.195, which was gradually replaced by lineage B.1.1.28 between May and June 2020. The second wave coincides with the emergence of the variant of concern (VOC) P.1, which evolved from a local B.1.1.28 clade in late November 2020 and replaced the parental lineage in <2 months. Our findings support the conclusion that successive lineage replacements in Amazonas were driven by a complex combination of variable levels of social distancing measures and the emergence of a more transmissible VOC P.1 virus. These data provide insights to understanding the mechanisms underlying the COVID-19 epidemic waves and the risk of dissemination of SARS-CoV-2 VOC P.1 in Brazil and, potentially, worldwide.
    5. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence
    1. 2021-06-10

    2. “Cases Rising Rapidly among Those with Incomplete Vaccinations.” Accessed June 15, 2021. https://covid.joinzoe.com/post/cases-rising-rapidly-among-those-with-incomplete-vaccinations.

    3. According to ZOE COVID Study figures, it is estimated there are currently 11,908 new symptomatic cases of COVID in the UK on average, based on PCR test data from up to five days ago [*]. This compares to 5,677 daily cases a week ago, an increase of 110%.The cases are higher and increasing faster in the unvaccinated population in the UK. When the data is divided, it shows that there are currently 1,917 new daily symptomatic cases of COVID in vaccinated people, an increase of 89% from 1,014 cases, compared to 9,991 new daily symptomatic cases in unvaccinated people, an increase of 114% from 4,662 cases last week. In terms of prevalence, on average 1 in 543 people in the UK currently have symptomatic COVID [1].
    4. Cases rising rapidly among those with incomplete vaccinations
    1. 2021-06-07

    2. Cirillo, Nicola, and Richard Doan. “Bell’s Palsy and SARS-CoV-2 Vaccines—an Unfolding Story.” The Lancet Infectious Diseases 0, no. 0 (June 7, 2021). https://doi.org/10.1016/S1473-3099(21)00273-5.

    3. Following the documentation of a case of Bell's palsy associated with vaccination,1Colella G Orlandi M Cirillo N Bell's palsy following COVID-19 vaccination.J Neurol. 2021; (https://dx.doi.org/10.1007%2Fs00415-021-10462-4 published online Feb 21.)Crossref PubMed Scopus (1) Google Scholar we were contacted by patients and colleagues from Canada, Australia, Europe, the UK, and United Arab Emirates. Questions raised were whether mRNA vaccine recipients are at increased risk of developing Bell's palsy, and what to recommend to individuals with a history of Bell's palsy.In their Comment, Al Ozonoff and colleagues2Ozonoff A Nanishi E Levy O Bell's palsy and SARS-CoV-2 vaccines.Lancet Infect Dis. 2021; 21: 450-452Summary Full Text Full Text PDF PubMed Scopus (2) Google Scholar considered key statistical and epidemiological aspects of SARS-CoV-2 vaccine trial safety data regarding the onset of facial paralysis. Here, we offer a different interpretation of their findings and statistical consideration of risks associated with mRNA and non-mRNA SARS-CoV-2 vaccines.
    4. 10.1016/S1473-3099(21)00273-5